These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 35932580)
1. KDM2A plays a dual role in regulating the expression of malignancy-related genes in esophageal squamous cell carcinoma. Wang J; Zhang ZY; Jiang J; Tang L; Wang XY; Wang Z; Yang XL; Yu XL; Huang CC; Chen F; Wan HS; Ye SJ Biochem Biophys Res Commun; 2022 Oct; 624():53-58. PubMed ID: 35932580 [TBL] [Abstract][Full Text] [Related]
2. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells. Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232 [TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
5. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617 [TBL] [Abstract][Full Text] [Related]
6. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription. Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062 [TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro. Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell. Xu WH; Liang DY; Wang Q; Shen J; Liu QH; Peng YB Mol Cell Biochem; 2019 Jun; 456(1-2):95-104. PubMed ID: 30604066 [TBL] [Abstract][Full Text] [Related]
9. The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma. Su X; Ding X; Ding C; Wang G; Fu C; Liu F; Shi J; He W Int Immunopharmacol; 2024 Aug; 137():112401. PubMed ID: 38878485 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA circFOXO3 regulates KDM2A by targeting miR-214 to promote tumor growth and metastasis in oral squamous cell carcinoma. Ai Y; Wu S; Zou C; Wei H J Cell Mol Med; 2022 Mar; 26(6):1842-1852. PubMed ID: 34117688 [TBL] [Abstract][Full Text] [Related]
11. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription. Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985 [TBL] [Abstract][Full Text] [Related]
12. Histone H3K36me2 demethylase KDM2A promotes bladder cancer progression through epigenetically silencing RARRES3. Lu B; Wei J; Zhou H; Chen J; Li Y; Ye L; Zhao W; Wu S Cell Death Dis; 2022 Jun; 13(6):547. PubMed ID: 35697678 [TBL] [Abstract][Full Text] [Related]
14. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma. Wang J; Li T; Li X; Zhang Y; Wang X BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411 [TBL] [Abstract][Full Text] [Related]
15. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1. Gao R; Dong R; Du J; Ma P; Wang S; Fan Z Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A. Shou T; Yang H; Lv J; Liu D; Sun X Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1. Wu D; He X; Wang W; Hu X; Wang K; Wang M Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639 [TBL] [Abstract][Full Text] [Related]
18. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4. Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541 [TBL] [Abstract][Full Text] [Related]
19. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway. Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864 [TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1. Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]